You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish Groups
|
---|---|
Published in |
Frontiers in immunology, July 2022
|
DOI | 10.3389/fimmu.2022.855730 |
Pubmed ID | |
Authors |
Mariana Bastos-Oreiro, Antonio Gutierrez, Juan Luís Reguera, Gloria Iacoboni, Lucía López-Corral, María José Terol, Valentín Ortíz-Maldonado, Jaime Sanz, Luisa Guerra-Dominguez, Rebeca Bailen, Alberto Mussetti, Pau Abrisqueta, Rafael Hernani, Hugo Luzardo, Juan-Manuel Sancho, Javier Delgado-Serrano, Antonio Salar, Carlos Grande, Leyre Bento, Sonia González de Villambrosía, Daniel García-Belmonte, Anna Sureda, Antonio Pérez-Martínez, Pere Barba, Mi Kwon, Alejandro Martín García-Sancho |
X Demographics
The data shown below were collected from the profiles of 30 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 15 | 50% |
Mexico | 2 | 7% |
India | 1 | 3% |
Singapore | 1 | 3% |
Italy | 1 | 3% |
Switzerland | 1 | 3% |
Unknown | 9 | 30% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 21 | 70% |
Practitioners (doctors, other healthcare professionals) | 6 | 20% |
Scientists | 3 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 29 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 4 | 14% |
Other | 3 | 10% |
Student > Doctoral Student | 2 | 7% |
Student > Master | 2 | 7% |
Student > Ph. D. Student | 2 | 7% |
Other | 4 | 14% |
Unknown | 12 | 41% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 12 | 41% |
Unspecified | 1 | 3% |
Chemistry | 1 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Unknown | 14 | 48% |
Attention Score in Context
This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2023.
All research outputs
#1,957,314
of 25,392,582 outputs
Outputs from Frontiers in immunology
#1,849
of 31,549 outputs
Outputs of similar age
#42,781
of 436,367 outputs
Outputs of similar age from Frontiers in immunology
#99
of 2,022 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 31,549 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 436,367 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 2,022 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.